Background Abdominal aortic aneurysm (AAA), a localized dilatation of the abdominal aorta,
has a prevalence of about 1.5%–3% among 65‐to 70‐year‐old males in Europe. AAA …

Objective The maximal aortic diameter is currently the only clinically applied predictor of
abdominal aortic aneurysm (AAA) progression. It is known that the risk of rupture is …

Abdominal aortic aneurysms (AAA) are fatal in 80% of the cases when ruptured.
Hypertension has been considered a potential risk factor for AAA; but the findings from …

Background Although data are inconsistent, angiotensin-converting enzyme inhibitors (ACE-
Is) have been associated with a reduced incidence of abdominal aortic aneurysm (AAA) …

BACKGROUND: Statins have been suggested to reduce expansion of abdominal aortic
aneurysms (AAAs) independent of lipid-lowering effects. METHODS: We assessed the …

Background Pharmacotherapy may represent a potential means to limit the expansion rate
of abdominal aortic aneurysms (AAAs). Studies evaluating the efficacy of different …

Objective This review describes ongoing efforts to develop a medical therapy to limit
abdominal aortic aneurysm (AAA) growth. Methods Data from animal model studies, human …

Abdominal aortic aneurysms (AAA) are prevalent among older adults and can cause
significant morbidity and mortality if not addressed in a timely fashion. Their etiology remains …

Objective There is currently no medical treatment proven to limit abdominal aortic aneurysm
(AAA) progression. The aim of this systematic review and meta-analysis was to pool data …

Background: Abdominal aortic aneurysm (AAA) refers to localized dilation of abdominal
aorta. AAA is largely asymptomatic, but aneurysmal rupture results in a high mortality rate …